|
显示项目 569191-569200 / 2348973 (共234898页)
<< < 56915 56916 56917 56918 56919 56920 56921 56922 56923 56924 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2022-03-04T06:10:56Z |
MDM2 expression in EBV-infected nasopharyngeal carcinoma cells
|
Wu H.-C.; Lu T.-Y.; Lee J.-J.; Hwang J.-K.; Lin Y.-J.; Wang C.-K.; CHIN-TARNG LIN |
| 國立成功大學 |
2012-08-15 |
MDM2 Overexpression Deregulates the Transcriptional Control of RB/E2F Leading to DNA Methyltransferase 3A Overexpression in Lung Cancer
|
Tang, Yen-An; Lin, Ruo-Kai; Tsai, Yo-Ting; Hsu, Han-Shui; Yang, Yi-Chieh; Chen, Chih-Yi; Wang, Yi-Ching |
| 義守大學 |
2014-12 |
MDM2 promoter polymorphism and p53 codon 72 polymorphism in chronic myeloid leukemia: the association between MDM2 promoter genotype and disease susceptibility, age of onset, and blast-free survival in chronic phase patients receiving imatinib
|
Yi-Chang Liu;Hui-Hua Hsiao;Wen-Chi Yang;Ta-Chih Liu;Chao-Sung Chang;Ming-Yu Yang;Pai-Mei Lin;Jui-Feng Hsu;Ching-Ping Lee;Sheng-Fung Lin |
| 亞洲大學 |
2006-10 |
MDM2 promotes cell mobility and invasiveness by regulating E-cadherin degradation
|
Yang, J-Y.;Zong, C. S.;Xia, Y.;Wei, Y.;Ali-Seyed, M.;Li, Z.;Broglio, K.;Berry, D. A.;Mien-Chie Hung |
| 高雄醫學大學 |
2009 |
MDM2 SNP309 does not confer an increased risk to oral squamous cell carcinoma but may modulate the age of disease onset.
|
楊奕馨; Hamid S;Yang YH;Peng KNL;Ismail SM;Zain RB;Lim KP;Mustafa WMW;Abraham MT;Teo SH;Cheong SC |
| 中國醫藥大學 |
2014-07 |
MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer
|
(Umadevi Thirumurthi);(Jia Shen);(Weiya Xia);(Adam M. LaBaff);(Yongkun Wei);(Chia-Wei Li);張為超(Wei-Chao Chang);(Chung-Hsuan Chen);林慧觀(Hui-Kuan Lin);(Dihua Yu);洪明奇(Mien-Chie Hung)* |
| 亞洲大學 |
2014 |
MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer.
|
Thirumurthi, ;Thirumurthi, U.;Shen, J.;Shen, J.;Xia, W.;Xia, W.;LaBaff, A.M;LaBaff, A.M.;Wei, Y.;Wei, Y.;Li, C-W.;Li, C-W.;Chang, W-C.;Chang, W-C.;Chen, C-H.;Chen, C-H.;洪明奇* |
| 高雄醫學大學 |
2014 |
MDM2基因啟動子及p53 R72P之基因多型性於慢性骨髓性白血病患之罹病風險,發病年齡,及慢性期病患以imatinib治療後疾病進展至芽細胞危象期之相關性
|
劉益昌;蕭惠樺;楊文祺;利大智;張肇松;楊敏瑜;林柏每;許瑞峰;李菁萍;林勝豐; Liu, Yi-Chang;Hsiao, Hui-Hua;Yang, Wen-Chi;Liu, Ta-Chih;Chang, Chao-Sung;Yang, Ming-Yu;Lin, Pai-Mei;Hsu, Jui-Feng;Lee, Ching-Ping;Lin, and Sheng-Fung |
| 高雄醫學大學 |
2007 |
MDM2基因啟動子基因多型性與慢性骨髓性白血病之關係
|
劉益昌;蕭惠樺;張建國;劉大智;張肇松;蔡慧珍;楊文祺;林勝豐 |
| 國立臺灣大學 |
2000 |
MDM2與 P21(WAF1) 在臺灣地區口腔癌中的表現及其預後價值
|
郭彥彬 |
显示项目 569191-569200 / 2348973 (共234898页)
<< < 56915 56916 56917 56918 56919 56920 56921 56922 56923 56924 > >>
每页显示[10|25|50]项目
|
